r.mensa
TL2 · Vaasa
Contributes reviews on supplier material. Based in Vaasa.
Joined 18 June 2025 · last posted 11d · groups: regional-apac
83Posts here
3Topics
1Solutions
1.7kLikes received
1.4kLikes given
22Badges
238Days visited
4.9kPosts read
Recent activity
Full stream-
What is genuinely unknown about long-term amylin agonism Replied, post #47 · Compounds › Cagrilintide & amylin analogues · 17 Jul 2026 · 0 likes Amylin analogues affect gastric emptying as well, so the mechanism overlaps the incretins in at least one place. That overlap is part of why the combination's…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #39 · Compounds › Secretagogues & GH axis · 14 Jul 2026 · 18 likes CJC-1295 exists in two forms in circulation — with and without the drug affinity complex — and they have very different half-lives. Product descriptions frequently do…
-
Follow-up: The most useful thing you learned here that was not the answer you came for Replied, post #21 · Lounge › Off topic · 8 Jul 2026 · 4 likes That is a fair summary of where the discussion has got to.
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #110 · Evidence › Journal club · 4 Jul 2026 · 1 like Good question, well framed, and I would like to see it answered properly.
-
Reading a syringe in poor light, and how to avoid needing to Replied, post #2 · marked as the solution · Devices › Syringes & needles · 1 Jul 2026 · 12 likes Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
-
Asking a follow-up: new topic or new reply? Replied, post #18 · Start Here › How to Ask · 20 Jun 2026 · 21 likes Whatever the answer on asking a follow-up turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the…
-
External review after an internal denial Replied, post #3 · Access › Insurance & coverage · 16 Jun 2026 · 0 likes I read the opening post twice before replying, because I had assumed the opposite. A peer-to-peer review is available in many systems and is frequently more productive…
-
A critique that turned out to be unfair, retracted by its author Replied, post #13 · Evidence › Study critique · 16 Jun 2026 · 0 likes On post #9 — agreed on the reasoning, with one qualification. Posting my critique numbers with the method attached so they can be discounted properly. Uncontrolled,…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #84 · Access › Insurance & coverage · 11 Jun 2026 · 29 likes My position on appeal is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
-
Prescription requirements and telehealth models — a second dataset Replied, post #58 · Sourcing › Regulatory · 8 Jun 2026 · 4 likes Seconded. It reads as careful rather than confident, which is the right register.
-
Coming back to: Time to steady state after a dose increase Replied, post #68 · Pharmacology › Pharmacokinetics · 3 Jun 2026 · 15 likes Dose proportionality across the studied range means dose arithmetic behaves the way you would naively expect. It is worth checking whether it holds for a given compound…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #120 · Compounds › Tirzepatide · 3 Jun 2026 · 1 like Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…